Piper Sandler Maintains Overweight Rating and Raises Price Target for Sight Sciences
Piper Sandler maintained its 'Overweight' rating on Sight Sciences and increased its price target from $9 to $12.
Stocks · News reference
Sight Sciences Announces Plans to Present at Upcoming Healthcare Conferences
Sight Sciences announced it will present at the Stifel 2026 Healthcare Conference on November 11, 2026.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Piper Sandler Reiterates Overweight on Sight Sciences, Raises Price Target to $12
CMS Establishes New Direct Practice Expense Supply Code for TearCare System
Sight Sciences announced that the Centers for Medicare & Medicaid Services (CMS) has established a new direct practice expense supply code for the TearCare System.
Sight Sciences Reports Third Quarter 2026 Financial Results
Sight Sciences, Inc. announced its financial results for the third quarter ended September 30, 2026, reporting record revenue of $24.9 million.
Sight Sciences Q3 EPS $(0.12) Beats $(0.13) Estimate, Sales $24.923M Beat $23.512M Estimate
8-K filing — Sight Sciences, Inc. (SGHT)
Filed: 2026-11-04 AccNo: 0001193125-26-447265 Size: 14 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits